Fezakinumab, CAS 1007106-86-6

Product Description: Fezakinumab is an interleukin-22 (IL-22) monoclonal antibody. Fezakinumab can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Patrick M Brunner, et al. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab. J Allergy Clin Immunol

CAS Number: 1007106-86-6

Molecular Weight: N/A

Compound Purity: 99.30

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99244-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99244-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK